1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. UROGEN PHARMA LTD
UroGen Pharma Ltd XNAS: URGN
20.87 1.99 (10.54%)
1.5M
XNAS Volume

XNAS 08 Sep, 2025 3:18 PM (EDT)

Board Meeting
The board meeting for UroGen Pharma Ltd is scheduled for today, for the purpose of H.C. Wainwright 27(th) Annual Global Healthcare Conference See details

UroGen Pharma Ltd - URGN - stock price prediction, stock price target, analyst ratings from 7 analysts

UroGen Pharma Ltd has a share price target of US$ 34, revenue growth forecast of 36.8%, and profit growth estimate of -14.9% for FY25, based on top 7 analyst calls.